Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next?

The evolving role of molecular profiling for therapeutic stratification in newly diagnosed ovarian cancer

Date

25 Jun 2021

Session

Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next?

Presenters

David SP Tan

Authors

D.S. Tan

Author affiliations

  • NUS-National University of Singapore-National University Health System (NUHS), 119228 - Singapore/SG
More

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings